Engineering microbial cells for the biosynthesis of natural compounds of pharmaceutical significance

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Jeandet, Philippe ^a   Vasserot, Yann ^a   Chastang, Thomas ^a   Courot, Eric ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTIOXIDANT; ANTIPARASITIC AGENT; HORMONE; IMMUNOLOGIC AGENT; ALKALOID; ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; POLYKETIDE; TERPENE;

ARTICLE; BIOENGINEERING; COST EFFECTIVENESS ANALYSIS; DRUG ISOLATION; DRUG POTENCY; DRUG SYNTHESIS; NONHUMAN; STRUCTURE ACTIVITY RELATION; BACTERIUM; BIOREACTOR; BIOSYNTHESIS; CELL ENGINEERING; CHEMISTRY; GENETIC ENGINEERING; HUMAN; METABOLISM; BACTERIA;

ALKALOIDS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOLOGICAL PRODUCTS; BIOREACTORS; CELL ENGINEERING; GENETIC ENGINEERING; HUMANS; POLYKETIDES; TERPENES;

EID: 84878133057     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/780145     Document Type: Article

References (92)

1. Chemler J. A., Koffas M. A., Metabolic engineering for plant natural product biosynthesis in microbes. Current Opinion in Biotechnology 2008 19 6 597 605 2-s2.0-57649100762 10.1016/j.copbio.2008.10.011
2. Ferrer-Miralles N., Domingo-Espín J., Corchero J., Vázquez E., Villaverde A., Microbial factories for recombinant pharmaceuticals. Microbial Cell Factories 2009 8, article 17 2-s2.0-65349147983 10.1186/1475-2859-8-17
3. Lee S. Y., Kim H. U., Park J. H., Park J. M., Kim T. Y., Metabolic engineering of microorganisms: general strategies and drug production. Drug Discovery Today 2009 14 1-2 78 88 2-s2.0-58149190072 10.1016/j.drudis.2008.08. 004
4. Du J., Shao Z., Zhao H., Engineering microbial factories for synthesis of value-added products. Journal of Industrial Microbiology and Biotechnology 2011 38 873 890
5. Papagianni M., Recent advances in engineering the central carbon metabolism of industrially important bacteria. Microbial Cell Factories 2012 11, article 50 10.1186/1475-2859-11-50
6. Marienhagen J., Bott M., Metabolic engineering of microorganisms for the synthesis of plant natural products. Journal of Biotechnology 2013 163 166 178 10.1016/j.jbiotec.2012.06.001
7. Xu P., Bhan N., Koffas M. A. G., Engineering plant metabolism into microbes: from systems biology to synthetic biology. Current Opinion in Biotechnology 2013 24 291 299
8. Donnez D., Jeandet P., Clément C., Courot E., Bioproduction of resveratrol and stilbene derivatives by plant cells and microorganisms. Trends in Biotechnology 2009 27 12 706 713 2-s2.0-70449730481 10.1016/j.tibtech.2009. 09.005
9. Rathbone D. A., Bruce N. C., Microbial transformation of alkaloids. Current Opinion in Microbiology 2002 5 3 274 281 2-s2.0-0036270712 10.1016/S1369-5274(02)00317-X (Pubitemid 34614939)
10. Keasling J., From yeast to alkaloids. Nature Chemical Biology 2008 4 9 524 525 2-s2.0-49949099517 10.1038/nchembio0908-524
11. Minami H., Kim J. S., Ikezawa N., Takemura T., Katayama T., Kumagai H., Sato F., Microbial production of plant benzylisoquinoline alkaloids. Proceedings of the National Academy of Sciences of the United States of America 2008 105 21 7393 7398 2-s2.0-44949247292 10.1073/pnas.0802981105 (Pubitemid 351830028)
12. Nakagawa A., Minami H., Kim J. S., Koyanagi T., Katayama T., Sato F., Kumagai H., A bacterial platform for fermentative production of plant alkaloids. Nature Communications 2011 2 1, article 326 2-s2.0-79957546214 10.1038/ncomms1327
13. Horinouchi S., Combinatorial biosynthesis of plant medicinal polyketides by microorganisms. Current Opinion in Chemical Biology 2009 13 2 197 204 2-s2.0-65349195249 10.1016/j.cbpa.2009.02.004
14. Hertweck C., The biosynthetic logic of polyketide diversity. Angewandte Chemie 2009 48 26 4688 4716 2-s2.0-69249202590 10.1002/anie.200806121
15. Shen B., Polyketide biosynthesis beyond the type I, II and III polyketide synthase paradigms. Current Opinion in Chemical Biology 2003 7 2 285 295 2-s2.0-0037398774 10.1016/S1367-5931(03)00020-6 (Pubitemid 36514961)
16. Abe I., Morita H., Structure and function of the chalcone synthase superfamily of plant type III polyketide synthases. Natural Product Reports 2010 27 6 809 838 2-s2.0-77953053139 10.1039/b909988n
17. Funa N., Ohnishi Y., Fujli I., Shibuya M., Ebizuka Y., Horinouchi S., A new pathway for polyketide synthesis in microorganisms. Nature 1999 400 6747 897 899 2-s2.0-0033606986 10.1038/23748 (Pubitemid 29406729)
18. Seshime Y., Juvvadi P. R., Fujii I., Kitamoto K., Discovery of a novel superfamily of type III polyketide synthases in Aspergillus oryzae. Biochemical and Biophysical Research Communications 2005 331 1 253 260 2-s2.0-17444429231 10.1016/j.bbrc.2005.03.160 (Pubitemid 40545169)
19. Chan Y. A., Podevels A. M., Kevany B. M., Thomas M. G., Biosynthesis of polyketide synthase extender units. Natural Product Reports 2009 26 1 90 114 2-s2.0-58149095417 10.1039/b801658p
20. Pfeifer B. A., Admiraal S. J., Gramajo H., Cane D. E., Khosla C., Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science 2001 291 5509 1790 1792 2-s2.0-0035793858 10.1126/science.1058092 (Pubitemid 32198984)
21. Wang Y., Boghigian B. A., Pfeifer B. A., Improving heterologous polyketide production in Escherichia coli by overexpression of an S-adenosylmethionine synthetase gene. Applied Microbiology and Biotechnology 2007 77 2 367 373 2-s2.0-35648976621 10.1007/s00253-007-1172-9 (Pubitemid 350029451)
22. Wada Y., Kobayashi T., Takahashi M., Nakanishi H., Mori S., Nishizawa N. K., Metabolic engineering of Saccharomyces cerevisiae producing nicotianamine: potential for industrial biosynthesis of a novel antihypertensive substrate. Bioscience, Biotechnology and Biochemistry 2006 70 6 1408 1415 2-s2.0-33745509212 10.1271/bbb.50660 (Pubitemid 43961818)
23. Ajikumar P. K., Xiao W. H., Tyo K. E. J., Wang Y., Simeon F., Leonard E., Mucha O., Phon T. H., Pfeifer B., Stephanopoulos G., Isoprenoid pathway optimization for Taxol precursor overproduction in Escherichia coli. Science 2010 330 6000 70 74 2-s2.0-77957329119 10.1126/science.1191652
24. Zhang W., Li Y., Tang Y., Engineered biosynthesis of bacterial aromatic polyketides in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 2008 105 52 20683 20688 2-s2.0-58549085193 10.1073/pnas.0809084105
25. Ma S. M., Zhan J., Watanabe K., Xie X., Zhang W., Wang C. C., Tang Y., Enzymatic synthesis of aromatic polyketides using PKS4 from Gibberella fujikuroi. Journal of the American Chemical Society 2007 129 35 10642 10643 2-s2.0-34848890676 10.1021/ja074865p (Pubitemid 350067459)
26. Wani M. C., Taylor H. L., Wall M. E., Coggon P., McPhail A. T., Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. Journal of the American Chemical Society 1971 93 9 2325 2327 2-s2.0-0015211527
27. Kingston D. G. I., The shape of things to come: structural and synthetic studies of taxol and related compounds. Phytochemistry 2007 68 14 1844 1854 2-s2.0-34447107974 10.1016/j.phytochem.2006.11.009 (Pubitemid 47030611)
28. Klein-Marcuschamer D., Ajikumar P. K., Stephanopoulos G., Engineering microbial cell factories for biosynthesis of isoprenoid molecules: beyond lycopene. Trends in Biotechnology 2007 25 9 417 424 2-s2.0-35548954677 10.1016/j.tibtech.2007.07.006 (Pubitemid 350147115)
29. Ajikumar P. K., Tyo K., Carlsen S., Mucha O., Phon T. H., Stephanopoulos G., Terpenoids: opportunities for biosynthesis of natural product drugs using engineered microorganisms. Molecular Pharmaceutics 2008 5 2 167 190 2-s2.0-42549093749 10.1021/mp700151b (Pubitemid 351579123)
30. Kirby J., Keasling J. D., Biosynthesis of plant isoprenoids: perspectives for microbial engineering. Annual Review of Plant Biology 2009 60 335 355 2-s2.0-67651030513 10.1146/annurev.arplant.043008.091955
31. Rohmer M., Knani M., Simonin P., Sutter B., Sahm H., Isoprenoid biosynthesis in bacteria: a novel pathway for the early steps leading to isopentenyl diphosphate. Biochemical Journal 1993 295 2 517 524 2-s2.0-0027368126 (Pubitemid 23315192)
32. Kuzuyama T., Seto H., Diversity of the biosynthesis of the isoprene units. Natural Product Reports 2003 20 2 171 183 2-s2.0-0037394552 10.1039/b109860h (Pubitemid 36453605)
33. Martin V. J. J., Piteral D. J., Withers S. T., Newman J. D., Keasling J. D., Engineering a mevalonate pathway in Escherichia coli for production of terpenoids. Nature Biotechnology 2003 21 7 796 802 2-s2.0-0038391517 10.1038/nbt833 (Pubitemid 36791399)
34. Pitera D. J., Paddon C. J., Newman J. D., Keasling J. D., Balancing a heterologous mevalonate pathway for improved isoprenoid production in Escherichia coli. Metabolic Engineering 2007 9 2 193 207 2-s2.0-33847309176 10.1016/j.ymben.2006.11.002 (Pubitemid 46329511)
35. Zhao Y., Yang J., Qin B., Li Y., Sun Y., Su S., Xian M., Biosynthesis of isoprene in Escherichia coli via methylerythritol phosphate (MEP) pathway. Applied Microbiology and Biotechnology 2011 90 6 1915 1922 2-s2.0-79958232375 10.1007/s00253-011-3199-1
36. Ro D. K., Paradise E. M., Quellet M., Fisher K. J., Newman K. L., Ndungu J. M., Ho K. A., Eachus R. A., Ham T. S., Kirby J., Chang M. C. Y., Withers S. T., Shiba Y., Sarpong R., Keasling J. D., Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 2006 440 7086 940 943 2-s2.0-33645870422 10.1038/nature04640
37. Chang M. C. Y., Eachus R. A., Trieu W., Ro D. K., Keasling J. D., Engineering Escherichia coli for production of functionalized terpenoids using plant P450s. Nature Chemical Biology 2007 3 5 274 277 2-s2.0-34247182988 10.1038/nchembio875 (Pubitemid 46625834)
38. Engels B., Dahm P., Jennewein S., Metabolic engineering of taxadiene biosynthesis in yeast as a first step towards Taxol (Paclitaxel) production. Metabolic Engineering 2008 10 3-4 201 206 2-s2.0-44749083814 10.1016/j.ymben.2008.03.001
39. Kaspera R., Croteau R., Cytochrome P450 oxygenases of taxol biosynthesis. Phytochemistry Reviews 2006 5 2-3 433 444 2-s2.0-33845402189 10.1007/s11101-006-9006-4 (Pubitemid 44900359)
40. Jennewein S., Long R. M., Williams R. M., Croteau R., Cytochrome P450 taxadiene 5 α -hydroxylase, a mechanistically unusual monooxygenase catalyzing the first oxygenation step of taxol biosynthesis. Chemistry and Biology 2004 11 3 379 387 2-s2.0-2642518854 10.1016/j.chembiol.2004.02.022 (Pubitemid 39403877)
41. Kowalski R. J., Giannakakou P., Hamel E., Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol). Journal of Biological Chemistry 1997 272 4 2534 2541 2-s2.0-0031027531 10.1074/jbc.272.4.2534 (Pubitemid 27058547)
42. Mutka S. C., Carney J. R., Liu Y., Kennedy J., Heterologous production of epothilone C and D in Escherichia coli. Biochemistry 2006 45 4 1321 1330 2-s2.0-31544449418 10.1021/bi052075r (Pubitemid 43167199)
43. Tang L., Shah S., Chung L., Carney J., Katz L., Khosla C., Julien B., Cloning and heterologous expression of the epothilone gene cluster. Science 2000 287 5453 640 642 2-s2.0-0034723333 10.1126/science.287.5453.640 (Pubitemid 30070909)
44. Tang L., Chung L., Carney J. R., Starks C. M., Licari P., Katz L., Generation of new epothilones by genetic engineering of a polyketide synthase in Myxococcus xanthus. Journal of Antibiotics 2005 58 3 178 184 2-s2.0-17044390459
45. Jackson B. E., Hart-Wells E. A., Matsuda S. P. T., Metabolic engineering to produce sesquiterpenes in yeast. Organic Letters 2003 5 10 1629 1632 2-s2.0-0041728804 10.1021/ol034231x (Pubitemid 37161991)
46. Acton N., Roth R. J., On the conversion of dihydroartemisinic acid into artemisinin. Journal of Organic Chemistry 1992 57 13 3610 3614 2-s2.0-0026624764
47. Ro D. K., Ouellet M., Paradise E. M., Burd H., Eng D., Paddon C. J., Newman J. D., Keasling J. D., Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. BMC Biotechnology 2008 8, article 83 2-s2.0-57049089897 10.1186/1472-6750-8-83
48. Dietrich J. A., Yoshikuni Y., Fisher K. J., Woolard F. X., Ockey D., McPhee D. J., Renninger N. S., Chang M. C. Y., Baker D., Keasling J. D., A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450BM3. ACS Chemical Biology 2009 4 4 261 267 2-s2.0-65649123015 10.1021/cb900006h
49. Tsuruta H., Paddon C. J., Eng D., Lenihan J. R., Horning T., Anthony L. C., Regentin R., Keasling J. D., Renninger N. S., Newman J. D., High-level production of amorpha-4, 11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli. PLoS ONE 2009 4 2 2-s2.0-60849102798 10.1371/journal.pone.0004489 e4489
50. Hayashi A., Kimoto K., Studies on the mechanism of antihypertensive action by nicotianamine. Journal of Nutritional Science and Vitaminology 2010 56 4 242 246 2-s2.0-77957747043 10.3177/jnsv.56.242
51. Mazor Y., Blarcom T. V., Mabry R., Iverson B. L., Georgiou G., Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nature Biotechnology 2007 25 5 563 565 2-s2.0-34249680261 10.1038/nbt1296 (Pubitemid 46834839)
52. Westers L., Dijkstra D. S., Westers H., van Dijl J. M., Quax W. J., Secretion of functional human interleukin-3 from Bacillus subtilis. Journal of Biotechnology 2006 123 2 211 224 2-s2.0-33646122441 10.1016/j.jbiotec.2005.11. 007
53. Medina-Rivero E., Balderas-Hernández V. E., Ordoñez-Acevedo L. G., Paz-Maldonado L. M. T., Barba-De La Rosa A. P., De León- Rodríguez A., Modified penicillin acylase signal peptide allows the periplasmic production of soluble human interferon- γ but not of soluble human interleukin-2 by the Tat pathway in Escherichia coli. Biotechnology Letters 2007 29 9 1369 1374 2-s2.0-34547627639 10.1007/s10529-007-9395-5 (Pubitemid 47205846)
54. Palmer T., Sargent F., Berks B. C., Export of complex cofactor-containing proteins by the bacterial Tat pathway. Trends in Microbiology 2005 13 4 175 180 2-s2.0-16244380460 10.1016/j.tim.2005.02.002 (Pubitemid 40463319)
55. Xu J., Li W., Wu J., Zhang Y., Zhu Z., Liu J., Hu Z., Stability of plasmid and expression of a recombinant gonadotropin-releasing hormone (GnRH) vaccine in Escherichia coli. Applied Microbiology and Biotechnology 2006 73 4 780 788 2-s2.0-33751537479 10.1007/s00253-006-0547-7 (Pubitemid 44833024)
56. Wang Y., Chen H., Yu O., Metabolic engineering of resveratrol and other longevity boosting compounds. BioFactors 2010 36 5 394 400 2-s2.0-78651514625 10.1002/biof.126
57. Kiselev K. V., Perspectives for production and application of resveratrol. Applied Microbiology and Biotechnology 2011 90 2 417 425 2-s2.0-79954880557 10.1007/s00253-011-3184-8
58. Wang Y., Chen S., Yu O., Metabolic engineering of flavonoids in plants and microorganisms. Applied Microbiology and Biotechnology 2011 91 949 956
59. Jeandet P., Delaunois B., Aziz A., Donnez D., Vasserot Y., Cordelier S., Courot E., Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol. Journal of Biomedicine and Biotechnology 2012 2012 14 579089 10.1155/2012/579089
60. Langcake P., Disease resistance of Vitis spp. and the production of the stress metabolites resveratrol, ε -viniferin, α -viniferin and pterostilbene. Physiological Plant Pathology 1981 18 213 226
61. Adrian M., Jeandet P., Veneau J., Weston L. A., Bessis R., Biological activity of resveratrol, a stilbenic compound from grapevines, against Botrytis cinerea, the causal agent for gray mold. Journal of Chemical Ecology 1997 23 7 1689 1702 2-s2.0-0030812368 (Pubitemid 27347638)
62. Adrian M., Jeandet P., Effects of resveratrol on the ultrastructure of Botrytis cinerea conidia and biological significance in plant/pathogen interactions. Fitoterapia 2012 83 1345 1350
63. Jeandet P., Douillet-Breuil A. C., Debord S., Sbaghi M., Bessis R., Adrian M., Phytoalexins from the vitaceae: biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. Journal of Agricultural and Food Chemistry 2002 50 10 2731 2741 2-s2.0-0037041904 10.1021/jf011429s (Pubitemid 34493577)
64. Halls C., Yu O., Potential for metabolic engineering of resveratrol biosynthesis. Trends in Biotechnology 2008 26 2 77 81 2-s2.0-38349165313 10.1016/j.tibtech.2007.11.002
65. Delaunois B., Cordelier S., Conreux A., Clément C., Jeandet P., Molecular engineering of resveratrol in plants. Plant Biotechnology Journal 2009 7 1 2 12 2-s2.0-57649135035 10.1111/j.1467-7652.2008.00377.x
66. Jeandet P., Delaunois B., Conreux A., Donnez D., Nuzzo V., Cordelier S., Clément C., Courot E., Biosynthesis, metabolism, molecular engineering, and biological functions of stilbene phytoalexins in plants. BioFactors 2010 36 5 331 341 2-s2.0-78651502974 10.1002/biof.108
67. Austin M. B., Noel J. P., The chalcone synthase superfamily of type III polyketide synthases. Natural Product Reports 2003 20 1 79 110 2-s2.0-0037319699 10.1039/b100917f (Pubitemid 36219433)
68. Yu O., Jez J. M., Nature's assembly line: biosynthesis of simple phenylpropanoids and polyketides. Plant Journal 2008 54 4 750 762 2-s2.0-43549122822 10.1111/j.1365-313X.2008.03436.x (Pubitemid 351678041)
69. Huang L. L., Xue Z., Zhu Q. Q., Method for the production of resveratrol in a recombinant oleaginous microorganism. US patent 2009/0082286A1, 2009
70. Katz M., Förster J., David H., Schmidt H. P., Sendelius M., Bjørn S. P., Durhuus T. T., Fluxome Sciences A/S, Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof. US Patent 2008/0286844A1, 2008
71. Vannelli T., Xue Z., Breinig S., Qi W. W., Sariaslani F. S., Functional expression in Escherichia coli of the tyrosine-inducible tyrosine ammonia-lyase enzyme from yeast Trichosporon cutaneum for production of p- hydroxycinnamic acid. Enzyme and Microbial Technology 2007 41 4 413 422 2-s2.0-34447281814 10.1016/j.enzmictec.2007.03.013 (Pubitemid 47039259)
72. Xue Z., McCluskey M., Cantera K., Ben-Bassat A., Sariaslani F. S., Huang L., Improved production of p- hydroxycinnamic acid from tyrosine using a novel thermostable phenylalanine/tyrosine ammonia lyase enzyme. Enzyme and Microbial Technology 2007 42 1 58 64 2-s2.0-35148882050 10.1016/j.enzmictec.2007.07.025 (Pubitemid 47538737)
73. Trantas E., Panopoulos N., Ververidis F., Metabolic engineering of the complete pathway leading to heterologous biosynthesis of various flavonoids and stilbenoids in Saccharomyces cerevisiae. Metabolic Engineering 2009 11 6 355 366 2-s2.0-70449533072 10.1016/j.ymben.2009.07.004
74. Shin S. Y., Jung S. M., Kim M. D., Han N. S., Seo J. H., Production of resveratrol from tyrosine in metabolically-engineered Saccharomyces cerevisiae. Enzyme and Microbial Technology 2012 51 211 216
75. Lim C. G., Fowler Z. L., Hueller T., Schaffer S., Koffas M. A. G., High-yield resveratrol production in engineered Escherichia coli. Applied and Environmental Microbiology 2011 77 10 3451 3460 2-s2.0-79958224739 10.1128/AEM.02186-10
76. Beekwilder J., Wolswinkel R., Jonker H., Hall R., De Rie Vos C. H., Bovy A., Production of resveratrol in recombinant microorganisms. Applied and Environmental Microbiology 2006 72 8 5670 5672 2-s2.0-33747371394 10.1128/AEM.00609-06
77. Watts K. T., Lee P. C., Schmidt-Dannert C., Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli. BMC Biotechnology 2006 6, article 22 2-s2.0-33645779318 10.1186/1472-6750-6-22
78. Huang L. L., Xue Z., Zhu Q. Q., Method for the production of resveratrol in a recombinant bacterial host cell. US Patent 2007/0031951A1, 2007
79. Katsuyama Y., Funa N., Miyahisa I., Horinouchi S., Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. Chemistry and Biology 2007 14 6 613 621 2-s2.0-34250304606 10.1016/j.chembiol.2007.05.004 (Pubitemid 46920981)
80. Becker J. V. W., Armstrong G. O., Van Der Merwe M. J., Lambrechts M. G., Vivier M. A., Pretorius I. S., Metabolic engineering of Saccharomyces cerevisiae for the synthesis of the wine-related antioxidant resveratrol. FEMS Yeast Research 2003 4 1 79 85 2-s2.0-1642401219 10.1016/S1567-1356(03)00157-0 (Pubitemid 38367534)
81. Zhang Y., Li S. Z., Li J., Pan X., Cahoon R. E., Jaworski J. G., Wang X., Jez J. M., Chen F., Yu O., Using unnatural protein fusions to engineer resveratrol biosynthesis in yeast and mammalian cells. Journal of the American Chemical Society 2006 128 40 13030 13031 2-s2.0-33749508478 10.1021/ja0622094 (Pubitemid 44527656)
82. Shin S. Y., Han N. S., Park Y. C., Kim M. D., Seo J. H., Production of resveratrol from p- coumaric acid in recombinant Saccharomyces cerevisiae expressing 4-coumarate:coenzyme A ligase and stilbene synthase genes. Enzyme and Microbial Technology 2011 48 1 48 53 2-s2.0-78149408612 10.1016/j.enzmictec. 2010.09.004
83. Wang Y., Yu O., Synthetic scaffolds increased resveratrol biosynthesis in engineered yeast cells. Journal of Biotechnology 2012 157 258 260
84. Wang Y., Halls C., Zhang J., Matsuno M., Zhang Y., Yu O., Stepwise increase of resveratrol biosynthesis in yeast Saccharomyces cerevisiae by metabolic engineering. Metabolic Engineering 2011 13 455 463
85. Sydor T., Schaffer S., Boles E., Considerable increase in resveratrol production by recombinant industrial yeast strains with use of rich medium. Applied and Environmental Microbiology 2010 76 10 3361 3363 2-s2.0-77952268311 10.1128/AEM.02796-09
86. Shivange A. V., Marienhagen J., Mundhada H., Schenk A., Schwaneberg U., Advances in generating functional diversity for directed protein evolution. Current Opinion in Chemical Biology 2009 13 1 19 25 2-s2.0-65249152992 10.1016/j.cbpa.2009.01.019
87. Yang G., Withers S. G., Ultrahigh-throughput FACS-based screening for directed enzyme evolution. ChemBioChem 2009 10 17 2704 2715 2-s2.0-73149119826 10.1002/cbic.200900384
88. Shao Z., Zhao H., Zhao H., DNA assembler, an in vivo genetic method for rapid construction of biochemical pathways. Nucleic Acids Research 2009 37 2, article e16 2-s2.0-59649108349 10.1093/nar/gkn991
89. Blanusa M., Schenk A., Sadeghi H., Marienhagen J., Schwaneberg U., Phosphorothioate-based ligase-independent gene cloning (PLICing): an enzyme-free and sequence-independent cloning method. Analytical Biochemistry 2010 406 2 141 146 2-s2.0-77956228537 10.1016/j.ab.2010.07.011
90. Liang J., Ning J. C., Zhao H., Coordinated induction of multi-gene pathways in Saccharomyces cerevisiae. Nucleic Acids Research 2013 41, article e54
91. Du J., Yuan Y., Si T., Lian J., Zhao H., Customized optimization of metabolic pathways by combinatorial transcriptional engineering. Nucleic Acids Research 2012 40, article e142
92. Xu P., Bhan N., Koffas M. A. G., Pathway and protein engineering approaches to produce novel and commodity small molecules. Current Opinion in Biotechnology. In press